gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · CRONHealthcarePharmaceuticals

Cronos Group Inc. Common Share (CRON)

$3.72+5.98%
Close Nov 5, 2026 · split-adjusted
Nov 5, 2026$3.72▲ 51.84% in range
Nov 5, 2025Low $2.30 · High $3.72Nov 5, 2026
What changed · written from our data
As of Nov 5, 2026

Cronos Group Inc. Common Share closed at $3.72 on Nov 5, up 5.98% — matching its 52-week closing high. Volume of 4.0M shares was 4.42× its 20-day average (well above normal).

Split-adjusted performance: +14.8% over one month, +44.7% over six months, +51.8% over one year.

In the quarter ended Jun 30, 2026, revenue was $70.60M, up 59.5% from a year earlier, with a net margin of 45.4%.

Short interest was 4.0M shares at the Oct 15 settlement, up 17.5% from the prior report (2.1% of float, 4.8 days to cover).

Market cap$1.37B368.4M shares
Revenue · quarter$70.6M+59.5% YoY
Diluted EPS$0.09—
P/E · TTM19.6×P/S 5.3×
Net margin45.4%Gross 65.8%
Dividend yieldNone
52-week range2.30 – 3.720.0% from high
Volume4.0M4.42× 20-day avg
Volatility · 60d31.4%Annualised
Short % of float2.1%4.8 days to cover
Net cash$797.0MCash $797.0M
Next earnings—Not scheduled
Split-adjusted performance
1W +10.7%1M +14.8%3M +20.0%6M +44.7%YTD +41.4%1Y +51.8%3Y +105.5%5Y −29.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum93
Revenue growth80
Net margin95
Value (low P/E)38
Size75

Industry medians: 6-month return −28.4%, revenue growth +5.9%, net margin −38.9%, P/E 15.0×.

Short interest

Details →
Shares short4.0M+17.5% vs prior
Days to cover4.8Settled Oct 15
% of float2.1%
Short vol. 10d33.6%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
CRONCronos Group Inc. Common Share$3.72+5.98%+44.7%+59.5%45.4%19.6$1.37B
ANABAnaptysBio$45.58−4.06%−31.9%−8.0%−206.9%—$1.36BCompare
KRSAKorsana Biosciences$30.43−0.43%————$1.39BCompare
INVAInnoviva$19.24−9.50%−15.6%+19.3%−69.8%3.9$1.39BCompare
DMRADamora Therapeutics$21.86−4.71%————$1.35BCompare
ETONEton Pharmaceutcials$47.15−7.04%+52.0%+98.6%30.8%106.2$1.35BCompare
MLYSMineralys Therapeutics$15.24−10.35%−48.1%———$1.35BCompare
RAPPRapport Therapeutics$23.72−8.52%−40.6%———$1.41BCompare
OCULOcular Therapeutix$6.43−9.94%−33.6%+0.1%−584.5%—$1.41BCompare

News about Cronos Group Inc. Common Share

All news →
Cronos (CRON) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research · Oct 23, 2026▲ PositiveCronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis CompanyGlobeNewswire Inc. · Oct 15, 2026▲ PositiveCRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out?Zacks Investment Research · Oct 9, 2026Neutral

Quick answers

What does Cronos Group Inc. Common Share do?
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio.
What is CRON's market cap?
$1.37B, based on the Nov 5 close of $3.72.
What is CRON's P/E ratio?
19.6× trailing-twelve-month earnings of $69.98M.
Does Cronos Group Inc. Common Share pay a dividend?
No regular cash dividend has been paid in the last year.
How much of CRON is sold short?
4.0M shares, 2.1% of float, as of Oct 15, 2026.
What sector is CRON in?
Healthcare, in the Pharmaceuticals industry.

About Cronos Group Inc. Common Share

Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.

HQ: Stayner, A6610 employeesListed Jun 3, 2016thecronosgroup.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology